FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma

(MedPage Today) -- The FDA announced approval of the Hepzato Kit melphalan injection system as liver-directed therapy for uveal melanoma metastases. The approval stipulates use in adults with unresectable liver metastases that affects less than...
Source: MedPage Today Public Health - Category: American Health Source Type: news